How A 3-Firm 'Joint Effort' Beat A $3.6B Pharma Antitrust Suit
By Bonnie Eslinger · July 5, 2023, 7:57 PM EDT
With Gilead and Teva facing trial on claims they bilked health plans and insurers out of $3.6 billion through a "pay-for-delay" scheme over two HIV drugs, the three law firms representing...
To view the full article, register now.